Page last updated: 2024-11-05

thalidomide and Gout

thalidomide has been researched along with Gout in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Gout: Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krause, A1
Märker-Hermann, E1

Reviews

1 review available for thalidomide and Gout

ArticleYear
[Spondyloarthritis including psoriatic arthritis].
    Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:40

    Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Certolizumab Pegol; Comorbidity

2014
chemdatabank.com